Key facts
- Centrus Diagnostics’s last known valuation is $24.0M (Jun 2025).
- It has raised $1.7M across 1 recorded rounds; the latest was Seed Round ($1.7M) in Jul 2024.
- Centrus Diagnostics has filed 1 Form D with the SEC, most recently Jun 2025 ($1.7M sold to 13 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 1 rounds
- ·Watchlist + deal alerts for Centrus Diagnostics
Funding rounds
1 roundsAbout Centrus Diagnostics
Developer of wearable health monitoring medical technology intended to improve the diagnosis and management of cardiovascular diseases. The company offers products, including smartbands, which are hospital-grade wearable devices that continuously monitor blood pressure and electrocardiographic (EKG) data, enabling patients to detect irregular heart rhythms like atrial fibrillation in real time.
- Sector
- Healthcare
- HQ
- Issaquah, WA, United States
- Founded
- 2022
- Website
- centrusdiagnostics.com/
- Ownership
- Privately Held (backing)
Centrus Diagnostics doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Centrus Diagnostics shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Centrus Diagnostics in its N-PORT filings yet. We sweep new filings monthly.